Brain protein levels and heart-related strokes
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at a brain protein called BDNF in people who've had a stroke caused by a clot from the heart. Researchers want to understand if BDNF levels can help explain why some strokes happen this way and may help doctors prevent future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an acute ischemic stroke (a stroke caused by a blood clot) confirmed by CT or MRI brain scan
- You were admitted to the Stroke Unit at Dijon Bourgogne University Hospital during the study period
- You had both a heart CT scan and brain CT scan within 24 hours of arriving at the hospital
- You are able to give informed consent to participate in the study
- You are not pregnant, recently postpartum, or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the nervous system's automatic functions (like heart rate and blood pressure) change after a stroke. It uses MRI scans and blood tests to find patterns that might help doctors better understand and treat these changes.
This study checks how the heart is doing in people who had a stroke caused by a clot and received treatment. It aims to learn how the heart recovers after the stroke is treated.
This study looks at how heart function changes soon after a new stroke, and whether a blood marker called GDF-15 can help explain or predict that change. It may help doctors better monitor heart stress after stroke and tailor care sooner.
This study looks for biological and imaging markers that may predict heart/vascular outcomes after an ischemic stroke. You may join if you are eligible for standard stroke treatment and can complete planned follow-up and MRI scans.
This study looks at how the brain and heart interact right after an acute ischemic stroke. It may help doctors better understand what happens in the first hours of stroke and improve monitoring or future treatments.
This study is looking at a protein in the blood called brain-derived tau, which may increase after a stroke. By measuring it over time, doctors hope to learn more about how the brain is healing and possibly predict recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.